Jim Mellon is a British entrepreneur and investor who serves as Chairman of his private investment company. See portfolio, sector focus and contact routes.
Jim Mellon is a British entrepreneur and investor who serves as Chairman of his private investment company, Burnbrae Group, with an entire career in asset management since graduating from Oxford in 1978. His investment thesis spans sectors including biotechnology, cellular agriculture, property, and natural resources, with significant focus on healthcare and late-stage life sciences. He typically invests across private and public companies, often taking controlling or major shareholder positions rather than acting as a passive follower. Notable portfolio companies include Juvenescence, which develops longevity therapies, and Agronomics, which invests in cellular agriculture firms. Mellon is a noted author who wrote *Moo’s Law* on cellular agriculture and *Juvenescence: Investing in the Age of Longevity*, reflecting his distinctive view that anti-aging drugs could be widely available by 2035. He also co-founded Endurance RP Group, a Hong Kong-based investment company focused on healthcare, and sits on boards including the Buck Institute for Research on Aging.
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in Isle of Man.
Investors like Jim Mellon · Full investor directory · Investor access · Company funding database